TALTZ (ixekizumab) injection

TALTZ (Ixekizumab)

TALTZ

ixekizumab

80 mg/mL

Eli Lilly and Company

Medical Use

TALTZ is a humanized interleukin-17A antagonist used to treat:

  • -Patients aged 6 years and older with moderate-to-severe plaque psoriasis who are suitable for systemic therapy or phototherapy.
  • -Adults with active psoriatic arthritis.
  • -Adults with active ankylosing spondylitis.
  • -Adults with active non-radiographic axial spondyloarthritis showing objective signs of inflammation